Capital Fund Management (CFM)’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-196,543
| Closed | -$2.13M | – | 1019 |
|
|
2024
Q2 | $2.13M | Buy |
196,543
+63,391
| +48% | +$688K | 0.01% | 478 |
|
|
2024
Q1 | $2.5M | Buy |
133,152
+60,246
| +83% | +$1.13M | 0.01% | 437 |
|
|
2023
Q4 | $1.58M | Buy |
72,906
+46,894
| +180% | +$1.02M | ﹤0.01% | 537 |
|
|
2023
Q3 | $535K | Buy |
26,012
+5,981
| +30% | +$123K | ﹤0.01% | 584 |
|
|
2023
Q2 | $942K | Sell |
20,031
-1,728
| -8% | -$81.3K | ﹤0.01% | 506 |
|
|
2023
Q1 | $913K | Buy |
21,759
+5,270
| +32% | +$221K | ﹤0.01% | 449 |
|
|
2022
Q4 | $629K | Buy |
16,489
+5,340
| +48% | +$204K | ﹤0.01% | 472 |
|
|
2022
Q3 | $437K | Sell |
11,149
-23,011
| -67% | -$901K | ﹤0.01% | 502 |
|
|
2022
Q2 | $1.1M | Sell |
34,160
-22,402
| -40% | -$724K | 0.01% | 451 |
|
|
2022
Q1 | $1.87M | Sell |
56,562
-19,761
| -26% | -$654K | 0.02% | 386 |
|
|
2021
Q4 | $3.25M | Buy |
76,323
+10,649
| +16% | +$453K | 0.02% | 275 |
|
|
2021
Q3 | $2.91M | Buy |
65,674
+12,363
| +23% | +$548K | 0.02% | 252 |
|
|
2021
Q2 | $3.03M | Sell |
53,311
-10,019
| -16% | -$569K | 0.02% | 277 |
|
|
2021
Q1 | $4.74M | Buy |
63,330
+52,590
| +490% | +$3.94M | 0.05% | 169 |
|
|
2020
Q4 | $929K | Buy |
+10,740
| New | +$929K | 0.01% | 374 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 805 |
|
|
2020
Q2 | – | Sell |
-16,161
| Closed | -$464K | – | 918 |
|
|
2020
Q1 | $464K | Buy |
+16,161
| New | +$464K | 0.01% | 550 |
|
|
2019
Q2 | – | Sell |
-1,297
| Closed | -$206K | – | 1007 |
|
|
2019
Q1 | $206K | Buy |
+1,297
| New | +$206K | ﹤0.01% | 735 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 1149 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 1201 |
|
|
2018
Q1 | – | Sell |
-3,065
| Closed | -$505K | – | 1154 |
|
|
2017
Q4 | $505K | Buy |
+3,065
| New | +$505K | ﹤0.01% | 659 |
|